BIONEXT.COM

Home

Discover the future of Drug Design. Learn how our BVS software platform will change the way you develop and test drugs! UE ranked our R&D project 32 in europe with a 1,8M budget. BVS Studio 2.0 released. BIONEXT released on April 6th a major version of its innovative 3D molecular visualization software. More from the News. Disruptive Technology. Paradigm shift. Traditional digital approaches works with Many Compound One Target. And it changes everything! Big-Data for Life Sciences. But in a new way.

http://www.bionext.com/

OVERVIEW OF bionext.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

10

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR BIONEXT.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.1 out of 5 with 15 reviews

5 star

9

4 star

1

3 star

4

2 star

0

1 star

1

Hey there! Start your review of bionext.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

CONTACTS AT BIONEXT.COM

NEXINT

Serge ALBOU

35, avenue●●●●●●●●●●al Leclerc

Boulogn●●●●●●●ancourt , 92100

FR

33.1●●●●9800

33.1●●●●1481

se●●●●●●●●●@nexint.com

View this contact

NEXINT

Serge ALBOU

35, avenue●●●●●●●●●●al Leclerc

Boulogn●●●●●●●ancourt , 92100

FR

33.1●●●●9800

33.1●●●●1481

se●●●●●●●●●@nexint.com

View this contact

NEXINT

Serge ALBOU

35, avenue●●●●●●●●●●al Leclerc

Boulogn●●●●●●●ancourt , 92100

FR

33.1●●●●9800

33.1●●●●1481

se●●●●●●●●●@nexint.com

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2001 May 08
UPDATED: 2014 March 27
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

24

YEARS
5

MONTHS
24

DAYS

NAME SERVERS

1: a.dns.gandi.net
2: b.dns.gandi.net
3: c.dns.gandi.net

REGISTRAR

GANDI SAS

WHOIS : whois.gandi.net

REFERRED : http://www.gandi.net

CONTENT

PAGES IN
THIS WEBSITE

10

SSL

EXTERNAL LINKS

4

SITE IP

217.70.184.38

LOAD TIME

0 sec

SCORE

6.2

PAGE TITLE

Home | bionext.com Reviews

<META> DESCRIPTION

Discover the future of Drug Design. Learn how our BVS software platform will change the way you develop and test drugs! UE ranked our R&D project 32 in europe with a 1,8M budget. BVS Studio 2.0 released. BIONEXT released on April 6th a major version of its innovative 3D molecular visualization software. More from the News. Disruptive Technology. Paradigm shift. Traditional digital approaches works with Many Compound One Target. And it changes everything! Big-Data for Life Sciences. But in a new way.

<META> KEYWORDS

1 toggle navigation

2 innovation

3 learn more

4 back to top

5 big data life sciences

6 follow us on

7 site map

8 legals

9 accessibility

10 credits

CONTENT

Page content here

KEYWORDS ON PAGE

toggle navigation,innovation,learn more,back to top,big data life sciences,follow us on,site map,legals,accessibility,credits

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Home | bionext.com Reviews

https://bionext.com

Discover the future of Drug Design. Learn how our BVS software platform will change the way you develop and test drugs! UE ranked our R&D project 32 in europe with a 1,8M budget. BVS Studio 2.0 released. BIONEXT released on April 6th a major version of its innovative 3D molecular visualization software. More from the News. Disruptive Technology. Paradigm shift. Traditional digital approaches works with Many Compound One Target. And it changes everything! Big-Data for Life Sciences. But in a new way.

INTERNAL PAGES

bionext.com

1

BVS Studio 2.0 released

http://www.bionext.com/bionext/about/news/bvs-studio-2-0-released.123.html

BVS Studio 2.0 released. BIONEXT released on April 6th a major version of its innovative 3D molecular visualization software. BIONEXT released on April 6th a major version of its innovative 3D molecular visualization software.

2

UE ranked our R&D project 32 in europe with a 1,8M€ budget

http://www.bionext.com/bionext/about/news/ue-ranked-our-r_et_d-project-32-in-europe-with-a.140.html

UE ranked our R&D project 32 in europe with a 1,8M budget. Our Eurostars project, BioScape, has been officially ranked by UE as 32 amongst 516 R&D projects in Europe (all activity sectors and company size). BioScape is a collaborative project bringing together european leaders in omics, structures and biology research. Its goal is to redefine the standards currently used in the academic and industry research to accelerate access and sharing of biological data.

3

Site map

http://www.bionext.com/bionext/site-map/site-map.44.html

4

News

http://www.bionext.com/bionext/about/news/news.36.html

BIONEXT raises 1M in seed funding. BIONEXT chosen as a 2014 Red Herring Europe Winner. UE ranked our R&D project 32 in europe with a 1,8M budget. BIONEXT selected for the French Biotech Tour. BVS Studio 2.0 released. BIONEXT released on April 6th a major version of its innovative 3D molecular visualization software. Bionext at BioTrinity 2012.

5

Home

http://www.bionext.com/bionext/home.134.html

Discover the future of Drug Design. Learn how our BVS software platform will change the way you develop and test drugs! BIONEXT raises 1M in seed funding. BIONEXT chosen as a 2014 Red Herring Europe Winner. UE ranked our R&D project 32 in europe with a 1,8M budget. More from the News. Disruptive Technology. Paradigm shift. Traditional digital approaches works with Many Compound One Target. Our disruptive technology changes the paradigm : Single Compound Multiple Targets. And it changes everything! But th...

UPGRADE TO PREMIUM TO VIEW 5 MORE

TOTAL PAGES IN THIS WEBSITE

10

LINKS TO THIS WEBSITE

mobilead.eu

mobiLead, Red Herring Top 100 Europe winner | mobiLead: Internet of Things enabler

http://mobilead.eu/red-herring-top-100-europe-winner

MobiLead, Red Herring Top 100 Europe winner. Amsterdam, Netherlands April 16. Red Herring announced its Top 100 award winners, recognizing Europe’s leading private companies and celebrating these startups’ innovations and technologies across their respective industries. MobiLead, Red Herring Top 100 Europe winner. A total of 18 French companies were selected for the 2014 Red Herring Top 100 Europe : Adways. MobiLead, 2014 Red Herring Top 100 Europe. Strategy and market penetration. This assessment wa...

redherring.com

2014 Red Herring Europe Top 100 Winners — Red Herring

http://www.redherring.com/events/red-herring-europe/2014winners

THE BUSINESS OF TECHNOLOGY. 2014 Red Herring Europe Top 100 Winners. Bewons Company S.r.l. BizOnRate d.o.o. Extreme Reality, Ltd. Hibox Systems Oy Ab. SOPSY / ZET.COM. The Institution JSPM AB. Vivocha S.p.A. Speak at Top 100. 2016 Top 100 Europe Winners. 2016 Red Herring Europe: Top 100 Short List. 2016 Red Herring Europe: Agenda. Press & Media. Top 100 Europe Past Winners. 2015 Top 100 Europe: Winners. 2014 Red Herring Europe Top 100 Winners. 2013 Red Herring Europe Top 100 Winners. Press & Media.

alsacebusinessangels.com

Quels sont les projets financés ? - Alsace Business Angels

http://www.alsacebusinessangels.com/quels-sont-les-projets-finances

Un projet à financer? Quels sont les projets financés? Jusquà aujourdhui, les projets présentés aux business angels couvraient principalement les domaines suivants :. TIC – Télécom – Electronique – Economie d’énergie – Chimie – Pharmacologie - Domotique – Restauration – Tourisme – Alimentaire – Environnement – BTP. Les business angels peuvent investir à titre individuel ou au travers de leur fonds dinvestissement régional. Leur premier fonds, doté de 890 000 euros, a permis de financer 8 projets :. Les b...

alsacecapital.eu

Cap Innov’Est | Alsace Capital

http://alsacecapital.eu/extrait-de-portefeuille/cap-innovest

À propos d’Alsace Capital. Secteur d'activité : Web. Métier : Plateforme web collaborative et pédagogique pour vétérinaires. Année d'investissement : 2016. Secteur d'activité : Web. Métier : Application communautaire pour la mobilité électrique. Année d'investissement : 2016. Https:/ fr.chargemap.com/. Secteur d'activité : Biotechnologies. Métier : Développement de peptides thérapeutiques transmembranaires. Année d'investissement : 2016. Secteur d'activité : Pharmaceutique. Année d'investissement : 2016.

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL LINKS TO THIS WEBSITE

4

OTHER SITES

bionexsolutions.net

Default Web Site Page

If you are the owner of this website, please contact your hosting provider: webmaster@bionexsolutions.net. It is possible you have reached this page because:. The IP address has changed. The IP address for this domain may have changed recently. Check your DNS settings to verify that the domain is set up correctly. It may take 8-24 hours for DNS changes to propagate. It may be possible to restore access to this site by following these instructions. For clearing your dns cache.

bionexsolutions.org

Default Web Site Page

If you are the owner of this website, please contact your hosting provider: webmaster@bionexsolutions.org. It is possible you have reached this page because:. The IP address has changed. The IP address for this domain may have changed recently. Check your DNS settings to verify that the domain is set up correctly. It may take 8-24 hours for DNS changes to propagate. It may be possible to restore access to this site by following these instructions. For clearing your dns cache.

bionext-care.com

ACTIVE 24

Http:/ page.active24.cz/default.domeny.cz/.

bionext-medical.com

ACTIVE 24

Http:/ page.active24.cz/default.domeny.cz/.

bionext.asia

Ce nom de domaine n'est pas disponible. Il a été enregistré via gandi.net. More information about the owner. Enregistrer votre nom de domaine. Chez Gandi, vous avez le choix sur plus d'une centaine d'extensions et vous bénéficiez de tous les services inclus (mail, redirection, ssl.). Rechercher un nom de domaine. Votre site dans le cloud? Découvrez Simple Hosting, notre cloud en mode PaaS à partir de 4 HT par mois (-50% la première année pour les clients domaine). It is currently being parked by the owner.

bionext.com

Home

Discover the future of Drug Design. Learn how our BVS software platform will change the way you develop and test drugs! UE ranked our R&D project 32 in europe with a 1,8M budget. BVS Studio 2.0 released. BIONEXT released on April 6th a major version of its innovative 3D molecular visualization software. More from the News. Disruptive Technology. Paradigm shift. Traditional digital approaches works with Many Compound One Target. And it changes everything! Big-Data for Life Sciences. But in a new way.

bionext.com.br

Bionext – Produtos Biotecnológicos

Notícias & Artigos. Fácil manuseio e aplicação por profissionais ou pacientes. 90% dos casos resolvidos com apenas 1 aplicação. Não necessita de cuidados especiais para estocagem. Além do domínio tecnológico do processo, bem como pedidos de patentes pendentes no Brasil e no resto do mundo, a Bionext , a partir de cepa selecionada, já está produzindo em larga escala, tendo desenvolvido por conta própria diversos equipamentos necessários para a fabricação e processamento final dos produtos resultantes.

bionext.es

Home

Nuestra meta 100% clientes satisfechos. Ofrecemos siempre la máxima calidad en nuestros servicios. Trabajamos con los mejores laboratorios. Disponemos de un servicio de atención muy rápido. Y además de un Servicio Express 24 horas. Nos adaptamos a los horarios de cada cliente. Realizamos los tratamientos con la máxima discrección. Todos nuestros técnicos estan titulados. Disponemos de cuatro directores técnicos. Controlando plagas desde 1982. Con los registros Z-0192-S. Nuevo diseño con más información.

bionext.fi

BioneXt // www.bionext.org

BioneXt nosti Tampereen seudun terveys-, hyvinvointi- ja bioteknologia-alan nopeimmin kasvavaksi Suomessa. BioneXt loppuraporttissa saavutukset ja tulevaisuuden suunnat. Innovatiivinen taittovoimaa muuttava tekomykiÃ kehitteillÃ. On investointi- ja kehitysohjelma joka edistää bioteknologian koulutuksen, huippututkimuksen, tuotekehityksen, kliinisen soveltamisen ja kansainvälisen kaupallistamisen mahdollisuuksien ja osaamisen kehittymistä. Tampereen yliopiston Rokotetutkimuskeskuksen ja virologian yksik&o...

bionext.net

郑州专业治疗牛皮癣医院_郑州治疗银屑病医院排名_郑州看银屑病医院-郑州市银屑病研究所

人民网讯 2014年9月13日，由中华中医药学会主办，.[ 详细. 怎么治疗初期银屑病大家谈及牛皮癣治疗，往往是.[ 详细. 医生简介杨淑莲，女，门诊医师，从事皮肤病. [详细]. 医生简介刘长江，男，门诊医师，从事银屑病. [详细]. 那么，对人来说，牛皮癣有哪些影响呢其实牛皮癣最明显的表现就是在外表，但是如果不注.[ 详细. 1、面部牛皮癣表现为点滴状，或呈脂溢性皮炎样，或呈.[ 详细. 郑州市银屑病研究所电话 0371-55159988 咨询QQ:1607779341.

bionext.nl

Home - Bionext

Ik sta achter biologisch. Lekker naar de BioBoer. Bio van het land tot op je bord. Bionext maakt zich sterk voor méér duurzame biologische voeding en landbouw. Het is onze passie om jou weer te verbinden met wat je eet, waar het vandaan komt en wie het maakt. Zodat je bewust kan kiezen wat goed is voor jou en voor de wereld om je heen. De cijfers en ontwikkeling van biologische landbouw en voeding in Nederland over 2016 op een rij. Word ook een filiaal! Wat kun jij doen? Koop, kook en beleef bio!